Loading...

Vicki L Wheelock, MD

Title(s)Professor, Neurology
SchoolUniversity of California, Davis
AddressACC/UCDMC, Suite 3700
CA 95817
Phone916-734-6287
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. Neurol Genet. 2020 Jun; 6(3):e430. Claassen DO, Corey-Bloom J, Dorsey ER, Edmondson M, Kostyk SK, LeDoux MS, Reilmann R, Rosas HD, Walker F, Wheelock V, Svrzikapa N, Longo KA, Goyal J, Hung S, Panzara MA. PMID: 32548276.
      View in: PubMed   Mentions:
    2. Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. Brain Behav. 2017 06; 7(6):e00639. Yuan M, Sperry L, Malhado-Chang N, Duffy A, Wheelock V, Farias S, O'Connor K, Olichney J, Shahlaie K, Zhang L. PMID: 28638698.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    3. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88(2):152-159. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M. PMID: 27913695.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    4. Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts. Cell Transplant. 2016; 25(4):677-86. Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Annett G, Wheelock V, Segal DJ, Nolta JA. PMID: 26850319.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    5. Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. Mol Ther. 2016 05; 24(5):965-77. Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, Wheelock V, Nolta JA. PMID: 26765769.
      View in: PubMed   Mentions: 30     Fields:    
    6. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol. 2016 Jan; 73(1):102-10. Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C. PMID: 26569098.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    7. The impact of oculomotor functioning on neuropsychological performance in Huntington disease. J Clin Exp Neuropsychol. 2016; 38(2):217-26. Carvalho JO, Long JD, Westervelt HJ, Smith MM, Bruce JM, Kim JI, Mills JA, Paulsen JS. PMID: 26745770.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD. Mov Disord. 2015 Oct; 30(12):1664-72. Long JD, Paulsen JS. PMID: 26340420.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    9. Prefrontal cortex white matter tracts in prodromal Huntington disease. Hum Brain Mapp. 2015 Oct; 36(10):3717-32. Matsui JT, Vaidya JG, Wassermann D, Kim RE, Magnotta VA, Johnson HJ, Paulsen JS. PMID: 26179962.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    10. Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease. Neuropsychology. 2015 Nov; 29(6):949-60. Kim JI, Long JD, Mills JA, McCusker E, Paulsen JS. PMID: 26011117.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden. J Int Neuropsychol Soc. 2015 Jan; 21(1):8-21. Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS. PMID: 26304055.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    12. Developing stem cell therapies for juvenile and adult-onset Huntington's disease. Regen Med. 2015; 10(5):623-46. Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA. PMID: 26237705.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    13. Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study. Appl Neuropsychol Adult. 2015; 22(4):287-92. Koster DP, Higginson CI, MacDougall EE, Wheelock VL, Sigvardt KA. PMID: 25495957.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar; 16(1-2):124-6. Oskarsson B, Wheelock V, Benatar M, Taylor JP, Joyce N, Chesak D, Jin LW. PMID: 25205077.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    15. Tracking motor impairments in the progression of Huntington's disease. Mov Disord. 2014 Mar; 29(3):311-9. Long JD, Paulsen JS, Marder K, Zhang Y, Kim JI, Mills JA. PMID: 24150908.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    16. Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis. Neurology. 2013 Feb 19; 80(8):e82. Goldenholz DM, Mehra N, Dahlin B, Cohen SH, Wheelock VL. PMID: 23420900.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. J Huntingtons Dis. 2013; 2(4):477-89. Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS. PMID: 25062732.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    18. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Hum Brain Mapp. 2014 Mar; 35(3):792-809. Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA. PMID: 23281100.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    19. Development of the Huntington disease work function scale. J Occup Environ Med. 2012 Oct; 54(10):1300-8. Brossman B, Williams JK, Downing N, Mills JA, Paulsen JS. PMID: 22995807.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Treatment of ?-aminobutyric acid B receptor-antibody autoimmune encephalitis with oral corticosteroids. Arch Neurol. 2012 Aug; 69(8):1061-3. Goldenholz DM, Wong VS, Bateman LM, Apperson M, Oskarsson B, Akhtar S, Wheelock V. PMID: 22507884.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2012 Jun; 83(6):612-9. Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS. PMID: 22451099.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    22. 8OHdG as a marker for Huntington disease progression. Neurobiol Dis. 2012 Jun; 46(3):625-34. Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS. PMID: 22414782.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    23. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol. 2012 Feb; 45(1):87-98. Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA. PMID: 22161544.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    24. Predictors of HVOT performance in Parkinson's disease. Appl Neuropsychol. 2011 Jul; 18(3):210-5. Higginson CI, Wheelock VL, Levine D, Pappas CT, Sigvardt KA. PMID: 21846220.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Cerebral venous sinus thrombosis presenting with auditory hallucinations and illusions. Cogn Behav Neurol. 2011 Mar; 24(1):40-2. Wong VS, Adamczyk P, Dahlin B, Richman DP, Wheelock V. PMID: 21467920.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Challenges assessing clinical endpoints in early Huntington disease. Mov Disord. 2010 Nov 15; 25(15):2595-603. Paulsen JS, Wang C, Duff K, Barker R, Nance M, Beglinger L, Moser D, Williams JK, Simpson S, Langbehn D, van Kammen DP. PMID: 20623772.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    27. In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet. 2010 Sep; 153B(6):1150-9. Williams JK, Erwin C, Juhl AR, Mengeling M, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS. PMID: 20468062.
      View in: PubMed   Mentions:
    28. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis. 2010 Dec; 40(3):531-43. Soneson C, Fontes M, Zhou Y, Denisov V, Paulsen JS, Kirik D, Petersén A. PMID: 20682340.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    29. Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet. 2010 Jul; 153B(5):1081-93. Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS. PMID: 20468061.
      View in: PubMed   Mentions:
    30. Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. Arch Neurol. 2008 Dec; 65(12):1582-9. PMID: 19064745.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    31. The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. J Clin Exp Neuropsychol. 2009 Jan; 31(1):65-72. Higginson CI, Wheelock VL, Levine D, King DS, Pappas CT, Sigvardt KA. PMID: 18608676.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    32. Cognitive deficits in essential tremor consistent with frontosubcortical dysfunction. J Clin Exp Neuropsychol. 2008 Oct; 30(7):760-5. Higginson CI, Wheelock VL, Levine D, King DS, Pappas CT, Sigvardt KA. PMID: 18608666.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    33. Predictors of diagnosis in Huntington disease. Neurology. 2007 May 15; 68(20):1710-7. Langbehn DR, Paulsen JS. PMID: 17502553.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    34. Recognition memory in Parkinson's disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis. J Clin Exp Neuropsychol. 2005 May; 27(4):516-28. Higginson CI, Wheelock VL, Carroll KE, Sigvardt KA. PMID: 15962695.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    35. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Mov Disord. 2005 Mar; 20(3):293-7. Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. PMID: 15584032.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    36. Dopamine dependency of cognitive switching and response repetition effects in Parkinson's patients. Neuropsychologia. 2005; 43(14):1990-9. Shook SK, Franz EA, Higginson CI, Wheelock VL, Sigvardt KA. PMID: 16243049.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    37. Temporal evolution of oscillations and synchrony in GPi/muscle pairs in Parkinson's disease. J Neurophysiol. 2005 Mar; 93(3):1569-84. Hurtado JM, Rubchinsky LL, Sigvardt KA, Wheelock VL, Pappas CT. PMID: 15496492.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    38. The relationship between executive function and verbal memory in Parkinson's disease. Brain Cogn. 2003 Aug; 52(3):343-52. Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA. PMID: 12907179.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    39. Predictors of nursing home placement in Huntington disease. Neurology. 2003 Mar 25; 60(6):998-1001. Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I. PMID: 12654967.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    Vicki L's Networks
    Concepts (195)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (24)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑